Theravance Biopharma Inc’s recently made public that its Officer RHONDA FARNUM acquired Company’s shares for reported $0.26 million on Jun 02 ’25. In the deal valued at $11.00 per share,24,000 shares were bought.
Then, Farnum Rhonda sold 4,000 shares, generating $36,000 in total proceeds. Upon selling the shares at $9.00, the SVP, COMM & MEDICAL AFFAIRS now owns 370,038 shares.
Before that, Farnum Rhonda sold 4,000 shares. Theravance Biopharma Inc shares valued at $36,000 were divested by the SVP, COMM & MEDICAL AFFAIRS at a price of $9.00 per share. As a result of the transaction, Farnum Rhonda now holds 309,565 shares, worth roughly $3.44 million.
Leerink Partners downgraded its Theravance Biopharma Inc [TBPH] rating to a Market perform from a an Outperform in a research note published on August 06, 2024; the price target was decreased to $10 from $15. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in mid April with a ‘”a Buy”‘ rating. Evercore ISI also remained covering TBPH and has decreased its forecast on January 08, 2024 with a “an In-line” recommendation from previously “an Outperform” rating. SVB Leerink started covering the stock on May 23, 2022. It rated TBPH as “an Outperform”.
Price Performance Review of TBPH
On Tuesday, Theravance Biopharma Inc [NASDAQ:TBPH] saw its stock fall -0.27% to $11.12. Over the last five days, the stock has gained 19.83%. Theravance Biopharma Inc shares have risen nearly 18.17% since the year began. Nevertheless, the stocks have risen 30.98% over the past one year. While a 52-week high of $11.21 was reached on 06/03/25, a 52-week low of $7.44 was recorded on 04/07/25. SMA at 50 days reached $9.28, while 200 days put it at $9.05.
Levels Of Support And Resistance For TBPH Stock
The 24-hour chart illustrates a support level at 10.81, which if violated will result in even more drops to 10.49. On the upside, there is a resistance level at 11.63. A further resistance level may holdings at 12.13. The Relative Strength Index (RSI) on the 14-day chart is 70.56, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.98, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.06%. Stochastics %K at 81.07% indicates the stock is a selling.
How much short interest is there in Theravance Biopharma Inc?
A steep rise in short interest was recorded in Theravance Biopharma Inc stocks on 2025-05-15, growing by 0.43 million shares to a total of 4.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 3.6 million shares. There was a rise of 10.69%, which implies that there is a positive sentiment for the stock.
